We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
Cap. Flow
+$235M
Cap. Flow %
3.1%
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$71M
2
BAX icon
Baxter International
BAX
+$60.7M
3
TMUS icon
T-Mobile US
TMUS
+$60.1M
4
PRGO icon
Perrigo
PRGO
+$53.7M
5
NRG icon
NRG Energy
NRG
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.11%
2 Industrials 11.84%
3 Consumer Discretionary 11.65%
4 Technology 10.61%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNR
751
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$178K ﹤0.01%
+10,803
New +$187K
RNG icon
752
RingCentral
RNG
$5.18B
$175K ﹤0.01%
11,704
LEJU
753
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$172K ﹤0.01%
+1,596
New +$203K
ELGX
754
DELISTED
Endologix Inc
ELGX
$171K ﹤0.01%
+1,117
New +$139K
RES icon
755
RPC Inc
RES
$1.31B
$168K ﹤0.01%
12,849
-399,855
-97% -$6.16M
SVU
756
DELISTED
SUPERVALU Inc.
SVU
$167K ﹤0.01%
2,454
-12,698
-84% -$793K
STKL
757
DELISTED
SunOpta
STKL
$166K ﹤0.01%
+13,984
New +$175K
OSUR icon
758
OraSure Technologies
OSUR
$275M
$164K ﹤0.01%
+16,153
New +$145K
PGNX
759
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$155K ﹤0.01%
20,567
-148,090
-88% -$886K
OVV icon
760
Ovintiv
OVV
$16.6B
$152K ﹤0.01%
2,195
-14,170
-87% -$1.21M
MUX icon
761
McEwen Inc
MUX
$1.09B
$150K ﹤0.01%
+13,470
New +$189K
ASNA
762
DELISTED
Ascena Retail Group, Inc.
ASNA
$143K ﹤0.01%
+570
New +$141K
FBP icon
763
First Bancorp
FBP
$4.44B
$138K ﹤0.01%
+23,463
New +$121K
SAND
764
DELISTED
Sandstorm Gold
SAND
$136K ﹤0.01%
+40,000
New +$133K
WNC icon
765
Wabash National
WNC
$512M
$134K ﹤0.01%
+10,855
New +$124K
SA
766
Seabridge Gold
SA
$3.12B
$128K ﹤0.01%
+17,000
New +$128K
CRK icon
767
Comstock Resources
CRK
$3.88B
$127K ﹤0.01%
3,717
+1,078
+41% +$55.8K
GSAT icon
768
Globalstar
GSAT
$10.7B
$123K ﹤0.01%
+2,982
New +$114K
HIMX
769
Himax Technologies
HIMX
$2.4B
$122K ﹤0.01%
+15,129
New +$119K
GOL
770
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$120K ﹤0.01%
10,422
-36,210
-78% -$371K
AUY
771
DELISTED
Yamana Gold, Inc.
AUY
$117K ﹤0.01%
+29,128
New +$132K
PPP
772
DELISTED
Primero Mining Corp
PPP
$115K ﹤0.01%
+30,000
New +$122K
CPE
773
DELISTED
Callon Petroleum Company
CPE
$110K ﹤0.01%
2,016
-2,910
-59% -$172K
AMD icon
774
Advanced Micro Devices
AMD
$798B
$94K ﹤0.01%
35,107
-55,394
-61% -$152K
MFIC icon
775
MidCap Financial Investment
MFIC
$800M
$90K ﹤0.01%
+4,063
New +$97.3K

Similar funds

Marshall Wace's Q4 2014 Portfolio in Review

As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.

  • Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
  • Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
  • Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
  • Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
  • Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
  • Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
  • Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.

Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.